Bioventus (BVS) Share-based Compensation (2022 - 2026)
Bioventus' (BVS) quarterly Share-based Compensation came in at $3.3 million in Q1 2026, down 74.23% on a QoQ basis from $12.7 million in Q4 2025.
Bioventus (BVS) Share-based Compensation (2022 - 2026) Analysis & Trends
Bioventus (BVS) has 5 years of Share-based Compensation data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Share-based Compensation changed N/A year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.9 million (up 633.01% YoY) and the FY2025 annual result came in at $12.7 million, changed N/A from the prior year.
- Share-based Compensation declined to $3.3 million in Q1 2026, from $12.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $12.7 million in Q4 2025 to a low of -$11.3 million in Q4 2024.
- A 5-year average of $1.4 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 311.46% in 2024, down 734.25% in 2024.
- Tracing BVS's Share-based Compensation over 5 years: stood at -$10.8 million in 2022, then surged by 116.43% to $1.8 million in 2023, then slumped by 734.25% to -$11.3 million in 2024, then jumped by 212.49% to $12.7 million in 2025, then plunged by 74.23% to $3.3 million in 2026.
- The last three Share-based Compensation figures came in at $3.3 million (Q1 2026), $12.7 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 5.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 5.04 Mn |
| Jun 27, 2026 | 5.04 Mn |
| Mar 28, 2026 | 3.26 Mn |
| Mar 28, 2026 | 3.26 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Sep 27, 2025 | -6.05 Mn |
| Sep 27, 2025 | -6.05 Mn |
| Jun 28, 2025 | 6.06 Mn |
| Jun 28, 2025 | 6.06 Mn |
| Dec 31, 2024 | -11.26 Mn |
| Dec 31, 2024 | -11.26 Mn |
| Sep 28, 2024 | 2.49 Mn |
| Sep 28, 2024 | 2.49 Mn |
| Jun 29, 2024 | 5.78 Mn |
| Jun 29, 2024 | 5.78 Mn |
| Mar 30, 2024 | 2.99 Mn |
| Mar 30, 2024 | 2.99 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Dec 31, 2023 | 1.78 Mn |